REFERENCES
-
1
Lawrence J S, Johnson J B.
The presence of a circulating anticoagulant in a male member of a hemophiliac family.
Trans Am Clin Climatol Assoc.
1941;
57
223-231
-
2
Kasper C, Aledort L, Counts R et al..
Letter: A more uniform measurement of factor VIII inhibitors.
Thromb Diath Haemorrh.
1975;
34(3)
869-872
-
3
Verbruggen B, Novakova I, Wessels H, Boezeman J, van den Berg M, Mauser-Bunschoten E.
The Nijmegen modification of the Bethesda assay for factor VIII:C inhibitors: improved specificity and reliability.
Thromb Haemost.
1995;
73(2)
247-251
-
4
Favaloro E J, Bonar R, Duncan E et al..
Identification of factor inhibitors by diagnostic haemostasis laboratories: a large multi-centre evaluation.
Thromb Haemost.
2006;
96(1)
73-78
-
5
Favaloro E J, Bonar R, Duncan E et al..
Mis-identification of factor inhibitors by diagnostic haemostasis laboratories: recognition of pitfalls and elucidation of strategies. A follow up to a large multicentre evaluation.
Pathology.
2007;
39(5)
504-511
-
6
Peerschke E I, Castellone D D, Ledford-Kraemer M, Van Cott E M, Meijer P. NASCOLA Proficiency Testing Committee .
Laboratory assessment of factor VIII inhibitor titer: the North American Specialized Coagulation Laboratory Association experience.
Am J Clin Pathol.
2009;
131(4)
552-558
-
7
Favaloro E J, Lippi G, Adcock D M.
Preanalytical and postanalytical variables: the leading causes of diagnostic error in hemostasis?.
Semin Thromb Hemost.
2008;
34(7)
612-634
Emmanuel J FavaloroPh.D. M.A.I.M.S.
Department of Haematology, Institute of Clinical Pathology and Medical Research (ICPMR)
Westmead Hospital, WSAHS, Westmead, Australia
Email: emmanuel.favaloro@swahs.health.nsw.gov.au
